Tocilizumab increases EPC regeneration in rheumatoid arthritis

Scand J Rheumatol. 2014;43(6):528-30. doi: 10.3109/03009742.2014.926985. Epub 2014 Sep 15.

Authors

S Patschan¹, K Nemirovsky, E Henze, J Scholze, G A Müller, D Patschan

Affiliation

¹ Department of Nephrology and Rheumatology, University Hospital of Göttingen , Germany.

PMID: 25222920
DOI: 10.3109/03009742.2014.926985

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aged
Antibodies, Monoclonal, Humanized / therapeutic use*
Arthritis, Rheumatoid / drug therapy*
Arthritis, Rheumatoid / immunology
Arthritis, Rheumatoid / physiopathology
Endothelial Progenitor Cells / drug effects*
Endothelial Progenitor Cells / physiology
Female
Humans
Male
Middle Aged
Regeneration / drug effects*
Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

Antibodies, Monoclonal, Humanized
Tumor Necrosis Factor-alpha
tocilizumab